Enzolytics Stock Profit Margin
ENZC Stock | USD 0.0009 0.0001 12.50% |
Enzolytics fundamentals help investors to digest information that contributes to Enzolytics' financial success or failures. It also enables traders to predict the movement of Enzolytics Pink Sheet. The fundamental analysis module provides a way to measure Enzolytics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Enzolytics pink sheet.
Enzolytics |
Enzolytics Company Profit Margin Analysis
Enzolytics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Based on the latest financial disclosure, Enzolytics has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Enzolytics Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Enzolytics' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Enzolytics could also be used in its relative valuation, which is a method of valuing Enzolytics by comparing valuation metrics of similar companies.Enzolytics is currently under evaluation in profit margin category among its peers.
Enzolytics Fundamentals
Return On Asset | -7.05 | |||
Operating Margin | (19.24) % | |||
Current Valuation | 71.57 M | |||
Shares Outstanding | 2.44 B | |||
Price To Sales | 2,083 X | |||
Revenue | 190 K | |||
Gross Profit | 52.81 K | |||
EBITDA | (886.77 K) | |||
Net Income | (57.28 K) | |||
Cash And Equivalents | 5.76 K | |||
Total Debt | 233.12 K | |||
Current Ratio | 0.01 X | |||
Book Value Per Share | (0.63) X | |||
Cash Flow From Operations | 4.89 M | |||
Earnings Per Share | (4.76) X | |||
Beta | -0.0481 | |||
Market Capitalization | 125.65 M | |||
Total Asset | 3.31 M | |||
Net Asset | 3.31 M |
About Enzolytics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Enzolytics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enzolytics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enzolytics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Enzolytics Pink Sheet
Enzolytics financial ratios help investors to determine whether Enzolytics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Enzolytics with respect to the benefits of owning Enzolytics security.